Paul Ricard
Paul Ricard
  • Articles
  • Authors
Influencers overtaking journalists as news source — report
by Paul Ricard - June 15, 2023 - 8:42am
TikTok influencers and celebrities are increasingly taking over from journalists as the main source of news for young people, according to a report published Wednesday...
McCartney daughter gives intimate tour of Abbey Road
by Paul Ricard - January 3, 2023 - 11:45am
The daughter of pop megastar Paul McCartney has given an intimate peek into the hallowed halls of Abbey Road, the studio where he — and many other music stars — recorded masterpieces. 
Journalists have much to lose if Twitter dies
by Paul Ricard - November 24, 2022 - 6:10pm
Few will lose as much as journalists if Twitter dies, having grown reliant on its endless sources and instant updates despite the dangers and distortions that come with it.
Adding peanuts to young children's diet can help avoid allergy — study
by Paul Ricard - January 21, 2022 - 10:04am
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Protesters hit French streets to fight new vaccine pass
by Paul Ricard - January 16, 2022 - 9:12am
Thousands demonstrated in cities across France on Saturday against tighter restrictions on people not vaccinated against Covid-19, as parliamentary wrangling continued over a draft law.
More contagious, less severe: What we know about Omicron
by Paul Ricard - December 24, 2021 - 8:44am
A month after it was first detected in southern Africa, Omicron is now known to be far more contagious than previous variants of Covid-19 but appears to cause a less severe illness than its predecessors.
What next for COVID-19 after five million deaths?
by Paul Ricard - November 1, 2021 - 2:53pm
With the world poised to hit more than five million people officially dead from the coronavirus, experts tell AFP the pandemic's future path will depend greatly on vaccinations.
Has Delta killed the herd immunity dream?
by Paul Ricard - August 20, 2021 - 1:24pm
As the Delta variant continues its global surge, experts are questioning whether the long-held goal of achieving herd immunity from COVID-19 through vaccination is still viable.
What we know: First human case of H10N3 bird flu
by Paul Ricard - June 3, 2021 - 8:38pm
China revealed the first human case of H10N3 bird flu on Tuesday, an announcement that has so far raised no alarm among world health authorities. Here is what we know.
Ibuprofen does not worsen COVID-19 symptoms — study
by Paul Ricard - May 8, 2021 - 9:18am
Taking anti-inflammatory drugs like ibuprofen does not increase the risk of developing a severe form of COVID-19 or of dying from it, according to a new study, the largest so far on this class of medicines.
Contagious and concerning: What we know about COVID-19 variants
by Paul Ricard - May 1, 2021 - 10:00am
Fast-spreading coronavirus variants have ignited global concern over whether existing vaccines will be able to protect the world from a virus that is constantly mutating.
Clot questions over AstraZeneca and J&J vaccine
by Paul Ricard - April 14, 2021 - 7:18am
The AstraZeneca and Johnson & Johnson vaccines have come under suspicion of causing very rare but serious blood clots in a handful of cases among the millions vaccinated in the drive to bring the pandemic under...
Questions about AstraZeneca jab linger
by Paul Ricard - April 5, 2021 - 7:17am
Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population, and what causes them if they are, have continued...
Why have some countries paused the AstraZeneca jab?
by Paul Ricard - March 17, 2021 - 7:48am
Germany, Italy, France and at several other nations say they need time to determine whether the vaccine is in any way responsible for very rare incidents of unusual blood events. 
COVID-19 vaccines, side effects: What we know so far
by Paul Ricard - December 14, 2020 - 12:38pm
The distribution of the first vaccines for the coronavirus has raised hopes that the end of the pandemic may be in sight, but it has also sparked some concern about side effects. 
Mystery still shrouds COVID-19 origin
by Paul Ricard - December 1, 2020 - 2:41pm
While many scientists are racing to find vaccines to tame the spread of the coronavirus pandemic, other researchers are probing the past, trying to unravel one of the greatest mysteries of the virus: exactly where...
After year-long sprint, COVID-19 vaccines finally at hand
by Paul Ricard - November 26, 2020 - 12:05pm
Health authorities could give a green light for emergency use within weeks, which would mark the most rapid vaccine development for a pandemic in history — but many questions remain
How opening a window could help you avoid COVID-19
by Paul Ricard - October 9, 2020 - 10:27am
While billions are being spent on the search for a COVID-19 vaccine and treatment, experts say there may be something you can do to help avoid the virus that costs nothing: open the window.
Do masks help boost COVID-19 immunity?
by Paul Ricard - September 26, 2020 - 12:20pm
Could the mask -- already seen by many scientists as the most effective shield against Covid-19 -- have yet another benefit? Some researchers now believe that they expose wearers to smaller, less harmful doses of...
Progress, hope in treatment of severe COVID-19 cases
by Paul Ricard - September 9, 2020 - 8:02am
Doctors are now able to treat severe cases of the coronavirus much better than when the pandemic began, which could save many lives, experts in France and the United States said.
1 | 2
Are you sure you want to log out?

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

or sign in with